Search

Home > JAMA Network > JAMA Oncology : Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
Podcast: JAMA Network
Episode:

JAMA Oncology : Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
Category: Science & Medicine
Duration: 00:15:06
Publish Date: 2021-04-15 15:00:00
Description:

Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Total Play: 0